A Vaccine for Alzheimer’s Disease?

Alzheimer; News from the web:

Swiss biopharma AC Immune has made targeting Alzheimer’s disease, the leading form of dementia, a top priority. The company’s numerous candidates and platforms target several different proteins and pathways thought to have a central role in Alzheimer’s pathology. 2020 has brought mixed news for AC Immune. In July, the company announced that their candidate tau vaccine, ACI-35.030, had shown “encouraging” safety data at a lower dose and was to be progressed to a higher-dose group. However, September brought the disappointing news that their anti-tau antibody, semorinemab, did not meet its primary efficacy endpoints in a Phase 2 trial. To discuss AC Immune’s work, Technology Networks spoke to CEO Prof. Andrea Pfeifer.

https://www.technologynetworks.com/

Read all about it HERE

Fundraiser for Alzheimer

Alzheimer; News from the web:

Start a Facebook fundraiser and CVS Health will give $10
Support the Association by starting a #GivingTuesday Facebook fundraiser today, and CVS Health will kick off your efforts with a $10 donation. In addition, donations made to your fundraiser on #GivingTuesday (Dec. 1) are eligible for a match from Facebook. The funds you raise help to provide Alzheimer’s care and support and accelerate critical research.

Read all about it HERE